Glycopyrronium bromide

Glycopyrronium bromide is a muscarinic antagonist used for the symptomatic treatment of severe chronic obstructive pulmonary disease (COPD). It works by blocking the action of a chemical messenger (acetylcholine) in the lungs. This helps to reduce the narrowing of the airways that leads to the symptoms of COPD, such as breathlessness, wheezing and coughing. Glycopyrronium bromide is usually taken as an inhaler and is available as a generic drug.

Glycopyrronium bromide is a medication that belongs to the muscarinic antagonist group. It works by blocking the action of the acetylcholine, a neurotransmitter, on certain receptors in the body. This results in a decrease in secretions, such as saliva, sweat, and mucus.

Glycopyrronium bromide is used in a variety of settings, including:

  • Anesthesia: To reduce salivary, tracheobronchial, and pharyngeal secretions before surgery.
  • Peptic ulcer disease: To help decrease stomach acid production and relieve symptoms of peptic ulcers.
  • Chronic obstructive pulmonary disease (COPD): To help relieve symptoms of COPD, such as shortness of breath and wheezing.

Glycopyrronium bromide is available in a number of different forms, including tablets, injections, and an inhaler. The most common side effects of glycopyrronium bromide are dry mouth, constipation, dizziness, and drowsiness.

Here are some additional things to keep in mind about glycopyrronium bromide:

  • It is not available over-the-counter and can only be obtained with a prescription from a doctor.
  • It is important to take glycopyrronium bromide exactly as directed by your doctor.
  • Glycopyrronium bromide can interact with other medications, so it is important to tell your doctor about all the medications you are taking before starting glycopyrronium bromide.
  • Glycopyrronium bromide can cause drowsiness, so it is important to avoid driving or operating machinery until you know how it affects you.
Anatomical Therapeutic Chemical Classification
A - Alimentary tract and metabolism
A03 Drugs for functional gastrointestinal disorders
A03A - Drugs for functional gastrointestinal disorders
A03AB Synthetic anticholinergics, quaternary ammonium compounds
Anatomical Therapeutic Chemical Classification
D - Dermatologicals
D11 Other dermatological preparations
D11A Other dermatological preparations
D11AA Antihidrotics
Anatomical Therapeutic Chemical Classification
R - Respiratory system
R03 Drugs for obstructive airway diseases
R03B - Other drugs for obstructive airway diseases, inhalants
R03BB Anticholinergics
Anatomical Therapeutic Chemical Classification
R - Respiratory system
R03 Drugs for obstructive airway diseases
R03A - Adrenergics, inhalants
R03AL Adrenergics in combinations with anticholinergics incl. triple combinations with corticosteroids
Anatomical Therapeutic Chemical Classification
R - Respiratory system
R03 Drugs for obstructive airway diseases
R03A - Adrenergics, inhalants
R03AL Adrenergics in combinations with anticholinergics incl. triple combinations with corticosteroids
Anatomical Therapeutic Chemical Classification
R - Respiratory system
R03 Drugs for obstructive airway diseases
R03A - Adrenergics, inhalants
R03AL Adrenergics in combinations with anticholinergics incl. triple combinations with corticosteroids
Anatomical Therapeutic Chemical Classification
R - Respiratory system
R03 Drugs for obstructive airway diseases
R03A - Adrenergics, inhalants
R03AL Adrenergics in combinations with anticholinergics incl. triple combinations with corticosteroids
Anatomical Therapeutic Chemical Classification
R - Respiratory system
R03 Drugs for obstructive airway diseases
R03A - Adrenergics, inhalants
R03AL Adrenergics in combinations with anticholinergics incl. triple combinations with corticosteroids
External Links